Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2021 Jul;83(1):119-145.
doi: 10.1016/j.jinf.2021.04.004. Epub 2021 Apr 11.

Asymptomatic COVID-19 cases among older patients despite BNT162b2 vaccination: A case series in a geriatric rehabilitation ward during an outbreak

Cristiano Donadio  1 , Antonio Rainone  1 , Adéline Gouronnec  2 , Joël Belmin  3 , Carmelo Lafuente-Lafuente  4
Affiliations
Comment

Asymptomatic COVID-19 cases among older patients despite BNT162b2 vaccination: A case series in a geriatric rehabilitation ward during an outbreak

Cristiano Donadio et al. J Infect. 2021 Jul.
No abstract available

PubMed Disclaimer

Conflict of interest statement

Declaration of Competing Interest J.B. received personal fees from Pfizer and Novartis. C.D., A.R., A.G. and C.L.L have no interest to declare.

Comment on

References

    1. Tré-Hardy M., Cupaiolo R., Papleux E., Wilmet A., Horeanga A., Antoine-Moussiaux T., Vecchia A.D. Reactogenicity, safety and antibody response, after one and two doses of mRNA-1273 in seronegative and seropositive healthcare workers. J Infect. 2021;S0163-4453(21):00158. doi: 10.1016/j.jinf.2021.03.025. -4Epub ahead of print. - DOI - PMC - PubMed
    1. Walsh E.E., Frenck R.W., Falsey A.R., Kitchin N., Absalon J., Gurtman A., Lockhart S. Safety and Immunogenicity of Two RNA-Based Covid-19 Vaccine Candidates. N Engl J Med. 2020;383(25):2439–2450. doi: 10.1056/NEJMoa2027906. - DOI - PMC - PubMed
    1. Polack F.P., Thomas S.J., Kitchin N., Absalon J., Gurtman A., Lockhart S., Perez J.L. Safety and efficacy of the BNT162b2 mRNA COVID-19 vaccine. N Engl J Med. 2020;383(27):2603–2615. doi: 10.1056/NEJMoa2034577. - DOI - PMC - PubMed
    1. Baden L.R., El Sahly H.M., Essink B., Kotloff K., Frey S., Novak R., Diemert D. Efficacy and safety of the mRNA-1273 SARS-CoV-2 vaccine. N Engl J Med. 2021;384(5):403–416. doi: 10.1056/NEJMoa2035389. - DOI - PMC - PubMed
    1. Petersen E., Koopmans M., Go U. Comparing SARS-CoV-2 with SARS-CoV and influenza pandemics. Lancet Infect Dis. 2020;20(9):e238–e244. doi: 10.1016/S1473-3099(20)30484-9. - DOI - PMC - PubMed